Amantadine News and Research

RSS
MIT researchers unravel the molecular structure of key coronavirus protein

MIT researchers unravel the molecular structure of key coronavirus protein

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Experimental drug offers hope for improving movement symptoms of Parkinson's

Experimental drug offers hope for improving movement symptoms of Parkinson's

Medicinal cannabis substitute may help unlock new treatment for Parkinson's disease

Medicinal cannabis substitute may help unlock new treatment for Parkinson's disease

Novel clinical trial to examine use of cannabidiol in people with Parkinson's-related psychosis

Novel clinical trial to examine use of cannabidiol in people with Parkinson's-related psychosis

New guideline released to improve diagnosis, care for people with prolonged disorders of consciousness

New guideline released to improve diagnosis, care for people with prolonged disorders of consciousness

NIST chemists publish new data on important compound’s thermodynamic properties

NIST chemists publish new data on important compound’s thermodynamic properties

Researchers synthetize molecules to block virus that causes influenza A

Researchers synthetize molecules to block virus that causes influenza A

Kansas State University's research shows promise to fight novel avian H7N9 influenza virus

Kansas State University's research shows promise to fight novel avian H7N9 influenza virus

New research shows promise in helping combat novel drug-resistant H7N9 influenza virus

New research shows promise in helping combat novel drug-resistant H7N9 influenza virus

New drug-resistant strain of bird flu appears to retain ability to cause serious disease in humans

New drug-resistant strain of bird flu appears to retain ability to cause serious disease in humans

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Some strains of avian H7N9 influenza develop resistance to antiviral drugs

Some strains of avian H7N9 influenza develop resistance to antiviral drugs

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

New AAN guideline recommends several treatments for people with Huntington's chorea

New AAN guideline recommends several treatments for people with Huntington's chorea

Adamas to present update on Nurelin program at CHI Targeting Parkinson's Disease Symposium

Adamas to present update on Nurelin program at CHI Targeting Parkinson's Disease Symposium

New tool to map extent of traumatic brain injury

New tool to map extent of traumatic brain injury

Parkinson's drug Amantadine may help brain injury victims: Study

Parkinson's drug Amantadine may help brain injury victims: Study

Bird flu updates

Bird flu updates

Tamiflu resistant flu on the rise: Study

Tamiflu resistant flu on the rise: Study